Methodology for a Variable Rate Control Strategy Development in Continuous Manufacturing Applied to Twin-screw Wet-Granulation and Continuous Fluid-bed Drying
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ierapetritou M, Muzzio F, Reklaitis G. Perspectives on the continuous manufacturing of powder-based pharmaceutical processes. AICHE J. 2016;62(6):1846–62. https://doi.org/10.1002/aic.15210 .
Chatterjee S. FDA perspective on continuous manufacturing—IFPAC Annual Meeting in Baltimore. January 2012. https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/UCM341197.pdf . Accessed 12.06.2017.
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA). Guidance for industry: PAT—a framework for innovative pharmaceutical development, manufacturing and quality assurance (Pharmaceutical cGMPs). 2004. https://www.fda.gov/downloads/drugs/guidances/ucm070305.pdf . Accessed 12.06.2017.
Allison G, Cain YT, Cooney C, Garcia T, Bizjak TG, Holte O, et al. Regulatory and quality considerations for continuous manufacturing May 20–21, 2014 Continuous Manufacturing Symposium. J Pharm Sci. 2015;104(3):803–12. https://doi.org/10.1002/jps.24324 .
The Brookings Institution. Promoting continuous manufacturing in the pharmaceutical sector—discussion guide. In: Center for Health Policy at Brookings. The Brookings Institution, 1775 Massachusetts Ave., Washington, DC. 2015. https://www.brookings.edu/wp-content/uploads/2015/10/Continuous-manufacturing-discussion-guide.pdf . Accessed 18.07.2017.
Warmington A. Continuous manufacturing: to be continued…. In: Pharmaceutical outsourcing. 15.03.2017. http://www.pharmoutsourcing.com/Featured-Articles/335938-Continuous-Manufacturing-To-Be-Continued/ . Accessed 11.07.2017.
Rockoff JD. Drug making breaks away from its old ways: continuous-manufacturing process can improve quality control, speed output. Wall Street J. 2015.
ICH. ICH harmonized tripartite guideline: pharmaceutical development. Q8(R2). 2009. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf . Accessed 12.06.2017.
Maguire J, Peng D. Office of Process and Facility (OPF), OPQ/CDER/FDA. How to identify critical quality attributes and critical process parameters. In: FDA/PQRI 2nd Conference. North Bethesda, Maryland. 2015. http://pqri.org/wp-content/uploads/2015/10/01-How-to-identify-CQA-CPP-CMA-Final.pdf . Accessed 12.06.2017.
Eriksson L, Johansson E, Kettaneh-Worl N, Wikström C, Wold S.. Design of experiments—principles and applications. 3 ed. MKS Umetrics AB; 2008.
Liu H, Galbraith SC, Ricart B, Stanton C, Smith-Goettler B, Verdi L, et al. Optimization of critical quality attributes in continuous twin-screw wet granulation via design space validated with pilot scale experimental data. Int J Pharm. 2017;525(1):249–63. https://doi.org/10.1016/j.ijpharm.2017.04.055 .
Novartis Pharma AG Basel Switzerland. Novartis internal documents; 2017.
Vercruysse J, Delaet U, Van Assche I, Cappuyns P, Arata F, Caporicci G, et al. Stability and repeatability of a continuous twin screw granulation and drying system. Eur J Pharm Biopharm. 2013;85(3):1031–8. https://doi.org/10.1016/j.ejpb.2013.05.002 .
Vercruysse J, Peeters E, Fonteyne M, Cappuyns P, Delaet U, Van Assche I, et al. Use of a continuous twin screw granulation and drying system during formulation development and process optimization. Eur J Pharm Biopharm. 2015;89:239–47. https://doi.org/10.1016/j.ejpb.2014.12.017 .
Rajalahti T, Kvalheim OM. Multivariate data analysis in pharmaceutics: a tutorial review. Int J Pharm. 2011;417(1–2):280–90. https://doi.org/10.1016/j.ijpharm.2011.02.019 .
Palzer S. Drying of wet agglomerates in a continuous fluid bed: influence of residence time, air temperature and air-flow rate on the drying kinetics and the amount of oversize particles. Chem Eng Sci. 2007;62(1–2):463–70. https://doi.org/10.1016/j.ces.2006.09.032 .
Lipsanen T, Antikainen O, Räikkönen H, Airaksinen S, Yliruusi J. Novel description of a design space for fluidised bed granulation. Int J Pharm. 2007;345(1–2):101–7. https://doi.org/10.1016/j.ijpharm.2007.05.051 .
Vercruysse J, Córdoba Díaz D, Peeters E, Fonteyne M, Delaet U, Van Assche I, et al. Continuous twin screw granulation: influence of process variables on granule and tablet quality. Eur J Pharm Biopharm. 2012;82(1):205–11. https://doi.org/10.1016/j.ejpb.2012.05.010 .
Kumar A, Alakarjula M, Vanhoorne V, Toiviainen M, De Leersnyder F, Vercruysse J, et al. Linking granulation performance with residence time and granulation liquid distributions in twin-screw granulation: an experimental investigation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2016;90:25–37. https://doi.org/10.1016/j.ejps.2015.12.021 .
Gorringe LJ, Kee GS, Saleh MF, Fa NH, Elkes RG. Use of the channel fill level in defining a design space for twin screw wet granulation. Int J Pharm. 2017;519(1–2):165–77. https://doi.org/10.1016/j.ijpharm.2017.01.029 .
Idakiev V, Mörl L. Study of residence time of disperse materials in continuously operating fluidized bed apparatus. 2013.
Burggraeve A, Monteyne T, Vervaet C, Remon JP, Beer TD. Process analytical tools for monitoring, understanding, and control of pharmaceutical fluidized bed granulation: a review. Eur J Pharm Biopharm. 2013;83(1):2–15. https://doi.org/10.1016/j.ejpb.2012.09.008 .
Burggraeve A, Van Den Kerkhof T, Hellings M, Remon JP, Vervaet C, De Beer T. Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation. Eur J Pharm Biopharm. 2010;76(1):138–46. https://doi.org/10.1016/j.ejpb.2010.06.001 .